rss
Br J Ophthalmol 2003;87:747-752 doi:10.1136/bjo.87.6.747
  • Original Article

Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision

  1. G L Ong1,
  2. L G Ripley2,
  3. R S B Newsom1,
  4. A G Casswell1
  1. 1Sussex Eye Hospital, Eastern Road, Brighton BN25BF, UK
  2. 2University of Sussex, Brighton, UK
  1. Correspondence to: Anthony G Casswell, Sussex Eye Hospital, Eastern Road, Brighton BN25BF, UK; tony.casswell{at}bsuh.nhs.uk
  • Accepted 3 October 2002

Abstract

Aim: To assess the effects of sight threatening diabetic retinopathy (STDR) on colour vision and to evaluate automated tritan contrast threshold (TCT) testing for STDR screening before significant visual loss.

Method: Patients were recruited from a hospital based photographic screening clinic. All subjects underwent best corrected Snellen visual acuity (BCVA) and those with 20/30 vision or worse were excluded. Automated TCT was performed with a computer controlled, cathode ray tube based technique. The system produced a series of sinusoidal, standardised equiluminant chromatic gratings along a tritan confusion axis. Grading of diabetic retinopathy was made by one of the team of experienced ophthalmic registrars (SpR) using slit lamp biomicroscopy and a 78D lens; HbA1c and urine albumin were also tested.

Results: Patients with STDR had significantly worse TCT despite normal BCVA (p<0.0001). TCT yielded a sensitivity of 100% for detecting diabetic maculopathy and 94% for STDR with a specificity of 95%. Logistic regression analyses showed that TCT (p<0.001) and HbA1c (p<0.05) correlated significantly with the presence of STDR but duration of diabetes, urine albumin counts, and BCVA failed to show any significant correlation. No associations between TCT and duration of disease, TCT and HbA1c, and TCT and urine albumin counts were found.

Conclusion: Tritan colour vision deficiency was observed in patients with STDR despite their normal BCVA. These results indicate that automated TCT assessment is an effective and clinically viable technique for detecting STDR, particularly diabetic maculopathy, before visual loss.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.